Sarti E, Manuell-Lee G, Mosqueda JL, Gabilondo F, de la Torre A, Arreguín V, Domínguez-Cheritt G, Macías AE, Córdova-Villalobos JA

Idioma: Español
Referencias bibliográficas: 31
Paginas: 289-298
Archivo PDF: 94.35 Kb.

RESUMEN

Se revisan aspectos importantes de la pandemia de influenza A (H1N1) al declararse el término de la contingencia en México. El sistema de vigilancia tuvo que adaptarse al preestablecido y modificarse sobre la marcha. La vigilancia virológica registró el desplazamiento de otros patógenos por el virus pandémico desde las primeras semanas de la epidemia. Se señalan los grupos de riesgo para el desarrollo de complicaciones y la necesidad de tratamiento temprano con antivirales, evitando así la saturación de las camas de Terapia Intensiva. Se analizan las dificultades de incrementar los servicios para pacientes graves. Se revisan las acciones preventivas como el uso del cubrebocas y la higiene de manos, así como la vacunación y las dificultades para su aplicación en el personal de salud. Se concluye con la necesidad de aprender las enseñanzas de la pandemia, describiendo los elementos necesarios para la preparación contra la siguiente.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Macías AE, De la Torre A, Bourlon MT, Leal PE, Moreno- Espinosa S, Huertas M, et al. Epidemic Influenza in Mexico: the broken dogma and its lessons. Rev Invest Clin 2009; 61: 94-7.

2. Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children-Southern California, March- April 2009. MMWR 2009, 24; 58: 400-02.

3. Chan M. Statement World Health Organization Director-General, 11 June 2009. http://www.who.int/mediacentre/ influenzaAH1N1_presstranscript_20090611.pdf.

4. World Health Organization Influenza, Avian: http://www.who.int/csr/disease/avian_influenza/en/

5. Ley general de salud: www.salud.gob.mx/unidades/cdi/legis/lgs/index-indice.htm

6. De la Torre A, López-Gatell H, Alpuche C, Macías A. Centinelas de la influenza pandémica en México: perspectivas de la vigilancia epidemiológica y el control. Revista Digital Universitaria 2010; 11(4). ISSN:1067-79.

7. OPS-CDC. Protocolo genérico para la vigilancia de la influenza, 2006. PAHO/HDM/CD/V/411/06.

8. WHO. Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance. July 2009. http://www.who.int/csr/disease/swineflu/WHO_case_definition_swine_flu_2009_04_29.pdf

9. Harper S, Bradley J, Englund, File T, Gravenstein S, Hayden F, et al. Seasonal Influenza in Adults and Children-Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1003-328.

10. Soper GA. The lessons of the pandemic. Science 1919; 49: 501-6.

11. Domínguez-Cherit G, Ñamendys-Silva S, De la Torre A, Macias A, Cordova-Villalobos JA. H1N1 Influenza Pandemic of 2009 Compared With Other Influenza Pandemics: Epidemiology, Diagnosis, Management, Pulmonary Complications, and Outcomes. Curr Infect Dis Rep 2010; 12: 204-10.

12. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team: Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 361: 1-10.

13. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374: 451-8.

14. Kitcharoen S, Pattapongsin M, Sawanyawisuth K, Angela V, Tiamkao S. Neurologic manifestations of pandemic (H1N1) 2009 virus infection. Emerg Infect Dis 2010; 16: 569-70.

15. Domínguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically Ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009; 302: 1880-7.

16. John G. Bartlett, Luciana Borio. The Current Status of Planning for Pandemic Influenza and Implications for Health Care Planning in the United States. Clin Infect Dis 2008; 46: 919-25.

17. Bourlon MT, Macias AE, De la Torre A, Gulias-Herrero A, Leal PE, Domínguez-Cherit G, Huertas M, et al. Organization of a third-level care hospital in Mexico City during the 2009 influenza epidemic. Arch Med Res 2009; 40: 681-6.

18. World Health Organization, Human Resources for Health: Models for projecting workforce supply and requirements. http://www.who.int/hrh/tools/models.pdf

19. Kumar A, Zarychanski R, Pinto R, et al: Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009; 302: 1872-9.

20. World Health Organization. Public health significance of virus mutation detected in Norway. Pandemic (H1N1) 2009 briefing note 17, 20 November 2009. http://www.who.int/csr/disease/swineflu/notes/brie-fing_20091120/en/index.html

21. Birnkrant D, Cox E. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 2009; 361: 2204-07.

22. Cheng PKC, Wong KKY, Mak GC, et al.: Performance of laboratory diagnostics for the detection of influenza A (H1N1) virus as correlated with the time after symptom onset and viral load. J Clin Virol 2010; 47: 182-5.

23. Macias AE, De la Torre A, Moreno-Espinosa S, Leal PE, Bourlon MT, Ruiz-Palacios GM. Controlling the novel A (H1N1) influenza virus: don´t touch your face! J Hosp Infect 2009; 73: 280-1.

24. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis 2003; 37: 1094-101.

25. Monto AS. The risk of seasonal and pandemic influenza: prospects for control. Clin Infect Dis 2009; 48(Suppl. 1): S20-S25.

26. Ajenjo MC, Woeltje KF, Babcock HM, Gemeinhart N, Jones M, Fraser VJ. Influenza vaccination among healthcare workers: ten-year experience of a large healthcare organization. Infect Control Hosp Epidemiol 2010; 31: 233-40.

27. Babcock HM, Gemeinhart N, Jones M, Dunagan WC, Woeltje KF. Mandatory influenza vaccination of health care workers: translating policy to practice. Clin Infect Dis 2010; 50: 459-64.

28. Parmet WE. Pandemic vaccines- the legal landscape. N Engl J Med 2010; 362: 1949-52.

29. Centers for Disease Control and Prevention (CDC). Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1)2009 monovalent vaccine. United States 2009-2010. MMWR Morb Mortal Wkly Rep 2010; 59: 657-61.

30. Cordova-Villalobos JA, Sarti E, Arzoz-Padres J, Manuell-Lee G, Mendez JR, Kuri-Morales P. The influenza A (H1N1) epidemic in Mexico. Lessons learned. Health Res Policy Syst 2009; 28: 7-21.

31. World Health Organization. Reglamento Sanitario Internacional 2005. http://www.who.int/gb/ebwha/pdf_files/WHA58/WHA58_3-sp.pdf